Performance of antenatal reflex DNA screening for Down’s syndrome

Journal of Medical Screening

Volumn 22, Issue 4, 2015, Pages 168-174

  Wald, Nicholas J ^a   Bestwick, Jonathan P ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antenatal screening; DNA analysis; Down s syndrome; Maternal plasma; Reflex testing

Indexed keywords

ANXIETY; CASE REPORT; CONTROLLED STUDY; COUNSELING; DNA SCREENING; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; MALE; RECALL; REFLEX; ADULT; DNA SEQUENCE; DOWN SYNDROME; GENETICS; LABORATORY DIAGNOSIS; MATERNAL SERUM SCREENING TEST; MULTIVARIATE ANALYSIS; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; STANDARDS;

ADULT; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MATERNAL SERUM SCREENING TESTS; MULTIVARIATE ANALYSIS; PREGNANCY; PRENATAL DIAGNOSIS; SEQUENCE ANALYSIS, DNA;

EID: 84945482783     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141315581005     Document Type: Article

References (22)

1. Chiu RWK, Akolekar R, Zheng YWL, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
2. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genet Med 2011;13:913-920.
3. Bianchi DW, Platt LD, Goldberg JD, et al. Maternal Blood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection bymaternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
4. Sparks AB, Stuble CA, Wang ET, et al. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy. Am J Obstet Gynecol 2012;206:319. e1-9.
5. Nicolaides KH, Syngelaki A, Ashoor G, et al. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012;207:374. e1-6.
6. Dan S, Wang W, Ren J, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11105 pregnancies with mixed risk factors. Prenat Diag 2012;32:1225-1232.
7. Zimmerman B, Hill M, Gemelos G, et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X and Y, using targeted sequencing of polymorphic loci. Prenat Diagn 2012;32:1233-1241.
8. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014;370:799-808.
9. Norton ME, Brar H, Weiss J, et al. Non-invasive chromosomal evaluation (NICE) study: results of a multicentre prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137. e1-8.
10. Chiu RWK. Noninvasive prenatal testing by maternal plasma DNA analysis: Current practice and future applications. J Clin Lab Invest 2014;74(Supp 244): 48-53.
11. Pergament E, Cuckle H, Zimmermann B, et al. Singlenucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol 2014;124:210-8.
12. Wald NJ. Community Corner: Opening the Pandora's box of prenatal genetic testing. Nature Medicine 2011;17:250-251.
13. Wald NJ, Bestwick JP. Incorporating DNA Sequencing into Current Prenatal Screening Practice for Down's Syndrome. PLoS ONE 8:e58732. doi:10. 1371/ journal. pone. 0058732.
14. Wald NJ, Rodeck C, Hackshaw AK, et al. First and Second trimester Antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 2003;10:56-104.
15. Wald NJ, Bestwick JP, Huttly WJ. Improvements in antenatal screening for Down's syndrome. J Med Screen 2013;20:7-14.
16. Office for National Statistics Birth Statistics. England and Wales; 2006, 2007, 2008 (FM1, Nos 35-37). London: The Stationary Office, 2008.
17. Morris JK, Mutton DE, Alberman E. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen 2002;9:2-6.
18. Morris JK, Wald NJ, Mutton DE, et al. Comparisons of models of maternal age-specific risk for Down syndrome live births. Prenat Diagn 2003;23:252-258.
19. Morris J, Mutton D, Alberman E. Corrections to maternal age-specific live birth prevalence of Down's syndrome. J Med Screen 2005;12:202.
20. Okun N, Teitelbaum M, Huang T, et al. The price of performance: a cost and performance analysis of the implementation of cell-free fetal DNA testing for Down syndrome in Ontario, Canada. Prenat Diagn 2013;34:350-6.
21. Nicolaides KJ, Wright D, Poon LC, et al. First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol 2013;42:41-50.
22. Morris S, Karlsen S, Chung N, et al. Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service. PLoS One 2014;9(4): e93559. doi: 10. 1371/journal. pone. 0093559.